As of June 2023, more than 1.1 million Americans have died of COVID-19. Adults older than 65 -;who make up just 16 percent of the population-;account for more than 75 percent of U.S. COVID-19 deaths and were hospitalized at three times the rate of younger people, highlighting the heightened vulnerability of this population.
FDA to launch pilot project for more transparency on generic drug delays
BETHESDA, MD — The FDA is rolling out a new six-month pilot program to provide more transparency to generic drug applicants on complicated regulatory issues,
October 22, 2024